Medtech company Covalon has grown its pediatric hospital client base to over 40 U.S. pediatric hospitals.
Four of the top five pediatric hospitals in the U.S., as ranked by U.S. News & World Report, are using a Covalon product, which include wound site and vascular access dressings. Covalon currently has a client base of more than 17 percent of United States pediatric hospitals, according to a Sept. 8 Covalon news release.
"It is not a mystery why 8 of the top 10 pediatric hospitals for cancer treatment in the United States are using Covalon products," said Brian Pedlar, CEO of Covalon. "Our products are specifically designed to help these patients heal better and safer, as recognized by healthcare providers that have dedicated themselves to the healing of some of our most vulnerable patients — our children."